Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on FERRATUM OYJ. We currently have 1 research reports from 1 professional analysts.
|12Dec16 06:30||GNW||Ferratum Oyj: Ferratum Bank Plc successfully places a EUR 25 million senior unsecured bond|
|21Nov16 06:30||GNW||Ferratum Oyj: Ferratum considers refinancing options for maturing bond|
|10Nov16 06:30||GNW||Ferratum Oyj: Ferratum Interim Report January - September 2016|
|08Nov16 14:08||GNW||Ferratum Oyj : Notice of report acc. to §§ 37v-x et seqq. WpHG (the German Securities Trading Act) with the aim of pan-European distribution|
|14Oct16 06:30||GNW||FERRATUM OYJ: Financial calendar 2017|
|06Sep16 19:33||GNW||FERRATUM OYJ: Ferratum publishes its guidance for 2016 and 2017|
|06Sep16 19:27||GNW||Ad hoc: Ferratum publishes its guidance for 2016 and 2017|
Frequency of research reports
Research reports on
Mobile consumer lender
13 Oct 15
Having listed in the Prime Standard segment of the Frankfurt Stock Exchange in February 2015, Ferratum (FRU) intends to continue the strong customer, revenue and profit growth reported for H115 by servicing the growing demand for mobile consumer financial services. The company is expanding its product list and the number of countries where products are on sale. It will launch mobile banking in Q116 and younger products have yet to be launched in many territories where the Microloan product is available.
21 Feb 17
Lighthouse Group* (LGT): Middle Britain growth (CORP) | Utilitywise* (UTW): Double-digit sales growth (CORP) | Trakm8* (TRAK): Earnings expectations cut again (CORP) | dotDigital* (DOTC): Myriad growth opportunities (CORP) | Artilium* (ARTA): Five-year Telenet deal secured and prepaid (CORP) | Netcall* (NET): Cloud investment pays off (CORP)
Small Cap Breakfast
16 Feb 17
Saffron Energy—Schedule One update. Raising £2.5m, expected Mkt Cap £7.7m. Admission due 24 Feb. Italian Oil & Gas Play Guinness Oil & Gas Exploration—Publication of prospectus. Seeking to raise £50m and invest in 15 exploration companies at launch, with plans to grow the portfolio to 30 positions during its lifetime. Issue closing 23 Feb. Arix Bioscience — Intention to float on the main market from the global healthcare and life science Company supporting medical innovation. Raised £52m in Feb 16 with investors including Woodford Investment Management
Share & share alike
14 Feb 17
The rally in the last fortnight, highlighted in the table, reflects a continued flow of positive updates and economic news. The FTSE 250, Small cap and Fledgling indices have reached record highs. We are in the lull ahead of results for those companies with a December year end, a welter of economic data regarding the UK economy, the State of the Union address in the US on 28 February and the UK Budget on Wednesday 8 March. We will learn at that stage the latest forecasts from the Office of Budget Responsibility. As highlighted previously, the reaction to corporate updates will continue to set the tone.
13 Feb 17
Surface Transforms* (SCE): H1 results confirm operational progress (CORP) | Premaitha Health* (NIPT): European diagnostics partnership (CORP) | Lok'nStore* (LOK): Filling existing stores, developing new ones (CORP) | Victoria* (VCP): Entry into the European flooring market (CORP) | eg solutions* (EGS): Exceptional H2 performance (CORP)
Middle Britain growth
21 Feb 17
The Company has achieved our 2017 estimate in 2016 with EBITDA of £2.2m, up 37% on 2015. We upgrade our estimates by 10% at the EBITDA level in 2017. If the shares traded even at the lower end of comparators, they would trade at 17p. We expect the share price to reach our upgraded 17p price target in the short term. Few companies enjoy the unique positioning which Lighthouse has to benefit from the assets of Middle Britain.
Small Cap Breakfast
15 Feb 17
Xafinity –Publication of prospectus. The pensions actuarial, consulting and administration business has conditionally raised £179.6m. At 139p. Due to join main market 16 Feb. Guinness Oil & Gas Exploration—Publication of prospectus. Seeking to raise £50m and invest in 15 exploration companies at launch, with plans to grow the portfolio to 30 positions during its lifetime. Issue closing 23 Feb. Arix Bioscience — Intention to float on the main market from the global healthcare and life science company supporting medical innovation. Raised £52m in Feb 16 with investors including Woodford Investment Management